Aptar partners with Kali Care to develop medical management technology

Business Wire

CRYSTAL LAKE - Aptar Pharma and Kali Care announced a partnership to address monitoring adherence in ophthalmic clinical trials.

The combination of Aptar Pharma's ophthalmic device expertise, and Kali Care's digital monitoring system for ophthalmic medications, is likely to have a significant impact in reducing the costs and complexity of ophthalmic clinical trials, the company said.

Kali Care, a Silicon Valley-based technology company, provides a sensor technology that allows clinicians to replace adherence assumptions in clinical trials with collected real-time data.

The move represents the latest step for Aptar Pharma in the development of drug delivery devices and collaborations in the connected health space.